Markets:

Overview

News

Currencies

International

Treasuries

IVERIC bio, Inc. - Common Stock (NQ:ISEE)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, Jul 10, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about IVERIC bio, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

Upward Trajectory For Biotech/Pharma M&A: Sector Trends Towards Pre-Pandemic Levels, Forecasts Positive For 2024 ↗

December 29, 2023

According to the Global Data report, the pharma sector in Q3 2023 witnessed deals worth $28 billion, down 28% from the $54 billion recorded in Q2 2023.

Via Benzinga

From AI to Obesity Drugs - Global Pharma Has $700B For M&A and Investments: Goldman Sachs ↗

July 07, 2023

Goldman Sachs compiled research suggesting the global pharmaceutical sector has approximately $700 billion available for M&A and investments. This significant financial reserve will be crucial as...

Via Benzinga

The Biotech Buying Bonanza: Why The FTC's Amgen Battle Won't Chill The Spree ↗

June 02, 2023

Big Pharma is facing a patent cliff that could siphon off billions in revenue.

Via Investor's Business Daily

The Latest Analyst Ratings for IVERIC bio ↗

April 25, 2023

Via Benzinga

Analyst Ratings for IVERIC bio ↗

April 03, 2023

Via Benzinga

Eye Care Sector Sees Several Large Acquisitions – Could This Ticker Be On Route For The Next Big Acquisition?

June 01, 2023

Eye Care Sector Sees Several Large Acquisitions – Could This Ticker Be On Route For The Next Big Acquisition?

Via News Direct

Eye Care Sector Sees Several Large Acquisitions – Could This Ticker Be On Route For The Next Big Acquisition? ↗

May 30, 2023

The Japanese healthcare company Astellas Pharma, Inc. (OTC: ALPMF) recently announced its acquisition of the biopharmaceutical company Iveric Bio

Via Benzinga

Why Shares of Annexon Are Plummeting Thursday ↗

May 25, 2023

Mixed trial results on a geographic atrophy eye drug led investors to sell the biotech stock.

Via The Motley Fool

10 Health Care Stocks With Whale Alerts In Today's Session ↗

May 08, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 4, 2023 ↗

May 04, 2023

Via Benzinga

IVERIC Bio (ISEE) Q4 2022 Earnings Call Transcript ↗

March 01, 2023

ISEE earnings call for the period ending December 31, 2022.

Via The Motley Fool

Benzinga's Top Ratings Upgrades, Downgrades For May 3, 2023 ↗

May 03, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 2, 2023 ↗

May 02, 2023

Via Benzinga

Earnings Scheduled For March 1, 2023 ↗

March 01, 2023

Companies Reporting Before The Bell • Globalstar (AMEX:GSAT) is expected to report quarterly loss at $0.01 per share on revenue of $38.75 million.

Via Benzinga

Why Apellis Pharmaceuticals, TG Therapeutics, and Viking Therapeutics Were on the Move Today ↗

May 01, 2023

These three biotech stocks were on the volatile side today.

Via The Motley Fool

Benzinga's Top Ratings Upgrades, Downgrades For May 1, 2023 ↗

May 01, 2023

Via Benzinga

Biotech Buying Bonanza: Iveric Bio Snags $5.9 Billion Deal From Astellas Pharma ↗

May 01, 2023

The company is working on a treatment for the eye disease known as geographic atrophy.

Via Investor's Business Daily

First Republic Folds Amid Banking Crisis, Elon Musk Expects Starship To Make Orbit On Next Launch, DOJ Probes Mastercard Over Anti-Competitive Debit-Card Practices: Today's Top Stories ↗

May 01, 2023

Benzinga

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

May 01, 2023

Via Benzinga

Nasdaq, S&P 500 Futures On Edge Over First Republic Failure, Tech Earnings: Analyst Pins Hopes On Fed's Next Move ↗

May 01, 2023

Stocks have reverted to their cautious ways on Monday amid a slew of market-moving catalysts.

Via Benzinga

Astellas Pharma Acquires Iveric Bio For $5.9B To Focus On 'Blindness & Regeneration' ↗

May 01, 2023

Japanese healthcare company Astellas Pharma Inc (OTC: ALPMY) has agreed to buy Iveric Bio Inc (NASDAQ: ISEE) for $40.00 per share in cash for a total equity value of

Via Benzinga

IVERIC bio, Ascendis Pharma And Other Big Stocks Moving Higher In Monday's Pre-Market Session ↗

May 01, 2023

U.S. stock futures traded mixed this morning. Here are some big stocks recording gains in today’s pre-market trading session. Apollomics, Inc. (NASDAQ: APLM) surged 58.4% to $7.35 in pre-market trading...

Via Benzinga

Top 5 Health Care Stocks That May Fall Off A Cliff This Quarter ↗

April 17, 2023

The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.

Via Benzinga

Why Eastside Distilling Shares Are Trading Lower By Over 25%; Here Are 20 Stocks Moving Premarket ↗

April 03, 2023

Gainers Hitek Global Inc. (NASDAQ: HKIT) jumped 25.5% to $6.98 in pre-market trading after gaining 11% on Friday. Hitek Global priced its initial public offering of 3,200,000 ordinary shares at a price...

Via Benzinga

Why Heska Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

April 03, 2023

Gainers Nogin, Inc. (NASDAQ: NOGN) shares surged 172.4% to $7.41. Guardforce AI Co., Limited (NASDAQ: GFAI) jumped 101% to $14.24 after climbing 50% on Friday.

Via Benzinga

Apellis Pharmaceuticals, VirTra And Other Big Stocks Moving Higher In Monday's Pre-Market Session ↗

April 03, 2023

U.S. stock futures traded mixed this morning. Here are some big stocks recording gains in today’s pre-market trading session.

Via Benzinga

Why Novavax Shares Are Trading Lower By Around 28%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

March 01, 2023

Gainers Reata Pharmaceuticals Inc (NASDAQ: RETA) shares jumped 171.5% to $84.67 after the company reported the FDA approval of SKYCLARYS for patients with Friedreich's Ataxia.

Via Benzinga

IVERIC bio's Geographic Atrophy Candidate Shows Significant Reduction In Disease Progression ↗

March 01, 2023

Via Benzinga

3D Systems, CarGurus, Sarepta Therapeutics And Other Big Stocks Moving Higher On Wednesday ↗

March 01, 2023

U.S. stocks traded lower, with the Dow Jones dropping around 80 points on Wednesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Apellis Surges To Four-Month High — Sending Rival Iveric Tumbling — On A First-Ever Approval ↗

February 21, 2023

Apellis is soon to launch its newest drug, Syfovre, for geographic atrophy patients.

Via Investor's Business Daily

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

IVERIC bio, Inc. - Common Stock (NQ:ISEE)

Headline News about IVERIC bio, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today